Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. (600329) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

Why is Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -4.57% and Operating profit at 6.69% over the last 5 years

PRE-TAX PROFIT(Q) At CNY 250.78 MM has Fallen at -75.14%
NET PROFIT(Q) At CNY 224.56 MM has Fallen at -74.33%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.33 times

With ROE of 39.69%, it has a very attractive valuation with a 3.31 Price to Book Value

Over the past year, while the stock has generated a return of 35.81%, its profits have risen by 285.1% ; the PEG ratio of the company is 0
At the current price, the company has a high dividend yield of 2.5

Market Beating Performance

The stock has generated a return of 35.81% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

28.52%

0.39

31.64%

China Shanghai Composite

13.33%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.57%

EBIT Growth (5y)

6.69%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.17

Sales to Capital Employed (avg)

0.94

Tax Ratio

15.22%

Dividend Payout Ratio

44.22%

Pledged Shares

Institutional Holding

ROCE (avg)

13.54%

ROE (avg)

15.94%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.31

EV to EBIT

34.62

EV to EBITDA

29.37

EV to Capital Employed

6.45

EV to Sales

4.06

PEG Ratio

0.03

Dividend Yield

2.51%

ROCE (Latest)

18.63%

ROE (Latest)

39.69%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

NET PROFIT(HY)

At CNY 1,777.93 MM has Grown at 326.84%

ROCE(HY)

Highest at 46.37%

DIVIDEND PAYOUT RATIO(Y)

Highest at 840.19%

RAW MATERIAL COST(Y)

Fallen by -68.33% (YoY

CASH AND EQV(HY)

Highest at CNY 6,804.87 MM

DIVIDEND PER SHARE(HY)

Highest at CNY 2.35

-21What is not working for the Company

PRE-TAX PROFIT(Q)

At CNY 250.78 MM has Fallen at -75.14%

NET PROFIT(Q)

At CNY 224.56 MM has Fallen at -74.33%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.33 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.35 times

NET SALES(Q)

Lowest at CNY 1,019.34 MM

Here's what is working for Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

Cash and Eqv

Highest at CNY 6,804.87 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Dividend per share

Highest at CNY 2.35

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio

Highest at 840.19%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -68.33% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

Net Sales

At CNY 1,019.34 MM has Fallen at -31.76%

over average net sales of the previous four periods of CNY 1,493.85 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 250.78 MM has Fallen at -75.14%

over average net sales of the previous four periods of CNY 1,008.58 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 224.56 MM has Fallen at -74.33%

over average net sales of the previous four periods of CNY 874.81 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 1.33 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales

Lowest at CNY 1,019.34 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Debtors Turnover Ratio

Lowest at 2.35 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio